Also trades as: 4552.T (JPX) · $vol 2M
JCRRF OTC
JCR Pharmaceuticals Co., Ltd.
1W: +10.1%
1M: +8.1%
3M: +14.7%
YTD: -24.2%
1Y: +inf%
3Y: -65.0%
5Y: -86.2%
$3.60
+0.27 (+8.11%)
Weekly Expected Move ±5.2%
$3
$3
$4
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$136M
+97.5% ▲
Capital Expenditures
$11.5B
-16.3% ▼
5Y CAGR: +8.8%
Free Cash Flow
-$11.6B
+24.3% ▲
Dividends Paid
$2.5B
+1.9% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$40M
+100.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $19.4B | $5.4B | $5.5B | -$6.4B | $2.2B |
| Depreciation & Amort. | $1.9B | $2.0B | $3.2B | $3.4B | $2.6B |
| Stock-Based Comp. | $177M | $173M | $71M | $9M | $0 |
| Change in Working Capital | -$9.0B | -$3.0B | -$6.1B | -$74M | -$6.3B |
| Other Non-Cash Items | -$133M | -$905M | $6.6B | -$2.4B | $1.4B |
| Operating Cash Flow | $9.3B | -$5.5B | $9.3B | -$5.5B | -$136M |
| — Investing Activities — | |||||
| Capital Expenditures | -$11.3B | -$8.6B | -$2.1B | -$9.9B | -$11.7B |
| Acquisitions (Net) | $8.2B | -$6.7B | -$600M | $145M | $0 |
| Investment Purchases | -$300M | -$906M | $0 | $0 | $0 |
| Investment Sales | $300M | $259M | $0 | $0 | $1.7B |
| Other Investing | -$84M | $922M | $5M | -$131M | -$2.6B |
| Investing Cash Flow | -$3.2B | -$15.0B | -$2.7B | -$9.9B | -$12.6B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $4.7B | $500M | $14.8B | $15.9B |
| Stock Repurchased | $10M | $10M | $15M | -$2.5B | $0 |
| Dividends Paid | -$2.2B | -$2.7B | -$2.5B | -$2.5B | -$2.5B |
| Other Financing | -$20M | -$23M | -$46M | -$55M | -$49M |
| Financing Cash Flow | -$2.2B | $1.9B | -$2.0B | $9.7B | $13.4B |
| Net Change in Cash | $4.5B | -$17.5B | $5.5B | -$5.6B | $40M |
| Cash End of Period | $30.7B | $13.3B | $18.8B | $13.2B | $14.1B |
| Free Cash Flow | -$2.0B | -$14.1B | $7.2B | -$15.4B | -$11.6B |